Market Winners & Losers: King Pharmaceuticals, MBIA Nov 20, 2009
Market Winners s: King Pharmaceuticals, MBIA - FOXBusiness ... Market Winners s: King Pharmaceuticals, MBIA ... King Pharmaceuticals Inc. () The pharmaceutical company saw its stock jump 5. (Fox News)
King 3Q profit falls on charges, but tops forecast Nov 6, 2009
Drug developer King Pharmaceuticals said Thursday its third-quarter profit was cut in half by charges for related to its $1 ... Shares of King Pharmaceuticals rose 46 cents, or 4. (Yahoo News -- Pharmaceutical Industry News)
ZymoGenetics hit with restraining orders Nov 5, 2009
The plaintiffs are , , King Pharmaceuticals Research and Development Inc. and. The plaintiffs accused ZymoGenetics (NASDAQ: ZGEN) of unfair competition, false advertising, trademark infringement and related claims, ZymoGenetics disclosed in a filing with the. (Puget Sound Business Journal, WA)
Top NBC Series Talent to Direct One-Minute Film Shorts on Personal Responsibility Oct 9, 2009
"This collaboration with NBC, which was developed and implemented by Boston-based advertising agency, Hill Holliday, is the latest addition to Liberty Mutuals Responsibility Project. According to Hill Hollidays CEO Mike Sheehan, This partnership between Liberty Mutual and NBC is just one example of how Liberty Mutual is leading innovation in consumer engagement. Were extremely proud to work with a partner like Liberty Mutual, which is at the forefront of new strategies to reach and... (Yahoo! Wire -- Entertainment News)
King says FDA approves 'abuse-resistant' pain drug Aug 14, 2009
King Pharmaceuticals Inc. said Thursday the Food and Drug Administration approved its drug Embeda, a painkiller that is designed to be abuse-resistant ... King Pharmaceuticals Inc. (Yahoo News -- Pharmaceutical Industry News)
King Pharmaceuticals reports 2Q profit drop Aug 7, 2009
Drug developer King Pharmaceuticals said Thursday its second-quarter profit dropped, as generic competition continued to hurt drug sales ... Shares of King Pharmaceuticals rose more than 3 percent, or 34 cents, to $9 ... King Pharmaceuticals. (Yahoo News -- Pharmaceutical Industry News)
PERRY GETS WRIST SLAP IN MERGER Jul 22, 2009
Perry's stake in Mylan followed a proposed merger with King Pharmaceuticals. Perry owned 7 million shares in King and supported the deal. (New York Post -- Business)
RAPP Announces New SVP, Brand Experience Director Norbert Fruteau De Laclos Jul 10, 2009
In 2007, a Super Bowl TV spot for the American Heart Association and King Pharmaceuticals led 1. 5 million visitors to the AHA website vs. the average 150K a year. (PR Newswire)
Watson to go global with $1.75 billion Arrow buy Jun 20, 2009
Arrow, which has about 1,000 employees worldwide, operates in the United States and Canada as Cobalt Pharmaceuticals, which recently has had a big product launch with a generic version of King Pharmaceuticals' (KG.N) Altace blood pressure drug. At 2. (Yahoo News -- Pharmaceutical Industry News)
Canadian Olympic Freestyle Skier Defies Gravity and a Life-threatening Allergy Jun 2, 2009
To raise awareness about severe allergies, Omischl is teaming with King Pharmaceuticals Canada - the distributors of EpiPen(R) - to let Canadians know that allergies should be taken seriously, but not to let them stop you from achieving your dreams ... About King Pharmaceuticals King, with offices in Mississauga, Ontario and headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company ... ----------------------------------- (1) Data collection for this study was... (Canada Newswire)
Participants in antidepressant drug trials are atypical patients, UT Southwestern researchers report May 13, 2009
Antidepressant medications were provided by Bristol-Myers Squibb, Forest, GlaxoSmithKline, King Pharmaceuticals, Organon, Pfizer and Wyeth. Dr. Trivedi has received consulting or speaking fees from Abbott, Abdi Brahim, Akzo (Organon), AstraZeneca, Bristol-Myers Squibb, Cephalon, Eli Lilly, Fabre-Kramer, Forest, GlaxoSmithKline, Janssen, Johnson on, Meade Johnson, Neuronetics, Parke-Davis, Pfizer, Sepracor, Vantage-Point and Wyeth. (EurekAlert!)
JSE consolidates May 12, 2009
Last Updated: 01:07pm 11 May 2009. 5 18 SPONSORED LINKS. (iAfrica.com)
King Pharma CEO's pay falls by nearly half in 2008 Apr 28, 2009
NEW YORK King Pharmaceuticals Inc. in 2008 paid its chief executive a little more than half his compensation from the previous year, largely because of a decline in stock and options awards, according to an Associated Press analysis of a regulatory filing ... King Pharmaceuticals Inc. (Yahoo News -- Pharmaceutical Industry News)
Vascular Solutions Announces First Quarter Results; Net Revenue Increases 12% to $15.8 Million; Net Income Increases 300% to $0.06 Per Share Apr 17, 2009
The primary reason for the revenue shortfall was the decision by our partner King Pharmaceuticals to suspend the clinical development of our Thrombi-Paste(tm) product, solely due to economic reasons. The resulting reduction in collaboration revenue, however, was essentially neutral to our net income since it was offset by an almost equal reduction in collaboration expenses. (Primezone Releases)
Drug Stocks Look Like Bargains After the Plunge: John Dorfman Mar 10, 2009
Disclosure note: Personally and for clients, I own shares in Merck, Pfizer, King Pharmaceuticals, and AstraZeneca Plc. (, chairman of Thunderstorm Capital in Boston, is a columnist for Bloomberg News. (Bloomberg -- Columnists)
Reducing painkiller abuse now a priority for drugmakers Feb 10, 2009
Companies asked to attend include makers of generic pills as well as brand-name products, like those from Johnson & Johnson, King Pharmaceuticals and Purdue Pharma. Regulators said continuing deaths from the drugs are due to both abuse by patients and inappropriate prescribing by physicians. (KSLA.com, LA)
FDA to Apply New Restrictions on Some Pain Pills Feb 10, 2009
The agency sent letters to 16 manufacturers of 24 products including Purdue Pharma LP, the maker of OxyContin, which is available in an extended release form, a unit of Johnson & Johnson (JNJ) that makes a fentanyl patch and King Pharmaceuticals Inc. (KG), the maker of an extended-release form of morphine. The letters told the drug makers of agency plans to require a risk evaluation and mitigation strategy, or REMS, "to ensure that the benefits of the drugs continue to outweigh the risks.". (SmartMoney)
FDA Seeks Plans to Reduce Misuse of Painkillers Feb 10, 2009
Companies asked to attend include makers of generic pills as well as brand-name products, like Johnson on's Duragesic patch, King Pharmaceuticals' extended-releases Avinza pills and Purdue Pharma's extended-release OxyContin. 1. (ABC News -- Wire)
FDA seeks plans to reduce painkiller deaths Feb 10, 2009
Companies asked to attend include makers of generic pills as well as brand-name products, like Johnson & Johnsons Duragesic patch, King Pharmaceuticals extended-releases Avinza pills and Purdue Pharmas extended-release OxyContin ... King Pharmaceuticals has asked the FDA to approve the drug Embeda, which it acquired through the purchase of Alpharma, as a tamperproof version of morphine for patients with chronic pain. (MSNBC -- Health)
Jobless claims soar in grim labor market Feb 7, 2009
A day earlier, PNC Financial Services Group, airplane maker Hawker Beechcraft Corp., Liz Claiborne Inc., King Pharmaceuticals Inc. and aerospace company Rockwell Collins Inc. announced layoffs. General Motors Corp., meanwhile, said it will offer buyouts to all of its hourly workers. (MSNBC -- Business)
